Dr. JP Clement brings more than 35 years of experience in drug safety and PV strategy. He has led worldwide PV functions at Janssen, Merck KGaA, Abbott, Sanofi, Onyx, and Cubist, building and optimizing organizations to meet the highest regulatory standards. As CEO and founder of JPCC Associates, he provides strategic leadership on global PV compliance, and supports biopharmaceutical companies through regulatory inspections, market approvals, international expansion, and safety crises. A physician by training, he earned his medical degree from Sorbonne Medical University, with additional pharmacology studies in Paris and Lyon, and practiced medicine for eight years prior to industry.

Back